论文信息 - Oligoarray comparative genomic hybridization in polycythemia vera and essential thrombocythemia

Oligoarray comparative genomic hybridization in polycythemia vera and essential thrombocythemia

Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative disorders (MPD) characterized by expansion of one or more myeloid lineages, which by definition results in erythrocytosis in PV and thrombocytosis in ET. The etiology and pathogenesis are still largely unknown. At

S. Mustjoki | S. Knuutila | I. Borze | E. Juvonen

[1] A. Panani. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications. , 2007, Cancer letters.

[2] M. Stratton,et al. JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. , 2007, The New England journal of medicine.

[3] D. Gilliland,et al. MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. , 2006, Blood.

[4] P. Campbell,et al. Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study , 2005, The Lancet.

[5] P. Campbell,et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders , 2005, The Lancet.

[6] R. Kralovics,et al. Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders. , 2005, Blood reviews.

[7] E. Ikkala,et al. Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings , 1998, Annals of Hematology.

[8] E. Ikkala,et al. Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications , 1993, British journal of haematology.